Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.

Balance Sheet for PharmaCyte Biotech Inc (PMCB)

$ 0.052475   0.001575 (+3.09%) Volume: 1.16m 3:55 PM EDT May 25, 2018
Statement: View:
Assets [+] in Thousands of Dollars
04/2017 04/2016 04/2015 04/2014 04/2013
Cash and Equivalents 3,464 1,921 2,700 3,616 199
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable - - - - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 74 110 1,468 570 1,649
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 3,539 2,031 4,168 4,187 1,848
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment - - - - 24
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total - - - - 24
Gross Fixed Assets - - - - 24
Accumulated Depreciation - - - - (24)
Net Fixed Assets - - - - -
Intangibles 3,549 3,549 3,549 3,549 -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 7 8 8 8 1,029
Total Non-Current Assets 5,129 5,129 5,129 5,129 1,029
Total Assets 8,667 7,160 9,297 9,316 2,877
Liabilities [+] in Thousands of Dollars
04/2017 04/2016 04/2015 04/2014 04/2013
Accounts Payable 366 336 497 332 1,025
Short Term Debt - - - - 420
Notes Payable - - - - -
Accrued Expenses 8 76 3 42 12
Accrued Liabilities 8 76 3 42 12
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 207 225 1,021 - 2,341
Total Current Liabilities 580 638 1,520 374 3,798
Long Term Debt - - - - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - - (500) -
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities - - - (500) 580
Total Liabilities 580 638 1,520 (126) 4,378
Preferred Shareholder's Equity - - - 500 580
Common Shareholder's Equity 8,087 6,523 7,777 8,942 (2,081)
Common Par 91 78 73 69 48
Additional Paid in Capital 97,130 91,135 86,330 75,999 39,896
Cumulative Translation Adjustments - - - - -
Retained Earnings (89,135) (84,692) (78,628) (68,700) (41,446)
Treasury Stock - - - - -
Other Equity Adjustments 2 1 1 - -
Total Capitalization 8,087 6,523 7,777 9,442 (1,501)
Total Equity 8,087 6,523 7,777 9,442 (1,501)
Total Liabilities & Shareholder's Equity 8,667 7,160 9,297 9,316 2,877
Cash Flow (4,444) (6,064) (10,855) (27,254) (1,597)
Working Capital 2,958 1,393 2,648 3,813 (1,950)
Free Cash Flow (3,339) (4,346) (5,060) (5,055) (1,037)
Invested Capital 8,087 6,523 7,777 8,942 (1,501)
Shares Outstanding - Common Class Only 905,349 781,233 732,760 690,616 482,106
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 905,349 781,233 732,760 690,616 482,106
Total Common Shares Outstanding 905,349 781,233 732,760 690,616 482,106
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 845,308 752,403 704,328 583,220 440,955
Diluted Weighted Shares Outstanding 845,308 752,403 704,328 583,220 482,106